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ABSTRACT
Introduction: Prostate cancer is the second most common male cancer and the second 
leading cause of cancer related death in the world. In Nigeria it is the most common male 
cancer constituting 11-12% of all male cancers. 
In most developing countries, prostate cancer screening is not widespread and men’s 
knowledge of the disease and screening methods for early detection is limited. 
Objective: This study assessed the knowledge, attitude and practice of prostate cancer 
screening among male staff of the University of Lagos, Lagos, Nigeria. 
Materials and Methods: A cross-sectional descriptive study using  self-administered 
questionnaires was carried out among 250 randomly selected male staff members of the 
University of Lagos aged 30 to >60 years. Data analysis was done using EPI-INFO version 
2007 software statistical package. Categorical variables in groups were compared using the 
chi-square test. The level of significance was set at p <0.05.
Results: The mean age of the respondents was 47.4±6 years. Overall, 164 (66%) were aware of 
prostate cancer and 145 (58%) were aware of prostate cancer screening methods. The commonest 
method known by these respondents was serum Prostate Specific Antigen (PSA) testing (59.3%). 
Only 71 (28.4%) respondents had undergone prostate cancer screening and the commonest reason 
for screening was on the recommendation of their doctor (47.9%). Of those who did not undergo 
testing, 32.4% were not aware of the test and in 30.2% of cases their doctor did not recommend it. 
Conclusion: This study revealed that although the respondents were aware of prostate cancer 
screening, few had taken the test. Because there is insufficient scientific evidence for the 
justification of screening in all men, the authors recommend that informed decision making 
should guide a decision to obtain screening for prostate cancer. This means that men should 
talk with their doctors to learn the nature and risks of prostate cancer, understand the benefit 
and risks of screening and decide whether prostate cancer screening is right for them.
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INTRODUCTION                                    
The prostate gland in men is capable of 
undergoing malignant changes leading to 
prostate cancer1. More than 70% of cases of 
adenocarcinoma of the prostate occur in 
men over the age of 65 years2. A man in his 
lifetime has about a 16% chance (1 in 6) of 
being diagnosed with prostate cancer and 3% 
(1 in 33) chance of dying of prostate cancer3. 
In the USA the estimated lifetime risk of 
being diagnosed with the disease is 17.6% for 
Whites and 20.6% for African-Americans. 
The lifetime risk of death from prostate 
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cancer is 2.8% and 4.7%, respectively3. The 
lifetime risk of being diagnosed with prostate 
cancer in the UK is one in twenty six4. In 
Nigeria, the prostate cancer risk was 2% of 
all patients based on a pool of 110.000 men5. 
Consequently, prostate cancer is likely to 
impact the life of a significant proportion of 
men that are alive today.
Prostate cancer contributes 6% of the 
entire global cancer burden6. Internationally, 
it is the 2nd most common cancer diagnosed 
among men (behind lung cancer) and the 
2nd leading cause of cancer death in men7. 
It accounts for 29% of all male cancers and 
11% of male cancer related deaths8. In the 
USA its incidence is second only to lung 
cancer 3. It is also now the most common 
cancer in men in the UK (not counting skin 
cancer)9. It accounts for nearly a quarter 
(24%) of all male cancers diagnosed4. It 
also remains the most commonly diagnosed 
non-cutaneous cancer and the second 
most common cause of cancer mortality 
in Australian men10. It is also the most 
common cause of cancer in Latin America 
and the Caribbean7. In Africa it is the third 
most common cause of cancer7. In Nigeria 
an analysis of adult male cancers examined 
every decade since independence confirmed 
that prostate cancer is the number one 
cancer in men and constitutes 11–12% of 
all male cancers11.
The worldwide prevalence rates have 
been estimated as 1.554.700 cases12. Its 
incidence varies widely between countries 
and ethnic populations, and disease rates 
differ 100 fold between populations12. 
The lowest yearly incidence rates occur in 
Asia (1.9 cases per 100.000 in China) and 
highest in North America and Scandinavia 
and especially in African-Americans (272 
per 100.000)12. In 2008, 186.000 new cases 
and 28.600 deaths were recorded in the 
USA2. In the UK the number of new cases 
diagnosed in 2006 was 35.515. Around 
301.500 new cases of prostate cancer were 
diagnosed in 25 member countries in the 
EU4. In Nigeria in 1997 Osegbe published 
data based on a prospective study of Nigerian 
men aged 45 years or older with prostatic 
symptoms and suggested that the incidence 
was 127/1000 men5. The Globocan 2002 
data base estimated that 6.236 new cases of 
prostate cancer would occur that year. The 
WHO in 2002 provided data for prostate 
cancer in Nigeria estimating that the age 
standardized incidence would be 96/100.0005.
With an estimated 254.000 deaths in 
2007, prostate cancer is the sixth leading 
cause of death in men.13 Its mortality varies 
widely among countries14. In Nigeria, which 
is the most populous country in Africa, a 
prospective study carried out by Osegbe in 
1997 stated that approximately 64% of the 
newly diagnosed patients died within two 
years5. 
In the developed world the probability of 
being diagnosed with cancer is more than 
twice as high as in developing countries. 
Fewer mortalities (50%) are recorded 
in the developed countries due to early 
detection, while in developing countries, 
80% of cancer victims are diagnosed 
with late stage incurable tumors, pointing 
to the need for much better detection 
programmes15. Some evidence have shown 
that recent recorded decline in cancer 
mortality observed in several countries 
was due to early detection15. Prostate 
cancer screening is an attempt to identify 
individuals with prostate cancer in a broad 
segment of the population, those whom 
there is no reason to suspect prostate 
cancer16. The principles of screening for 
prostate cancer are measurement of serum 
Prostate Specific Antigen (PSA) and digital 
rectal examination (DRE). 
Currently, there is no scientific consensus 
on effective strategies to reduce the risk of 
prostate cancer. Additionally, there is no 
agreement on the effectiveness of screening 
or its potential risk-benefit ratio. Therefore, 
public health agencies face significant 
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challenges in determining what actions to 
take to address prostate cancer. Given the 
uncertainty about the benefit of screening, the 
principal public health approach is to support 
informed decision making about screening.
Knowledge of prostate cancer and prostate 
cancer screening plays an important role in 
cancer screening utilization17. Researchers 
have found a correlation between knowledge 
and screening behaviours18. A large 
international survey carried out in Europe 
and the USA on general public awareness 
of prostate cancer in 2003 showed that there 
was a lack of awareness of prostate cancer19. 
In Nigeria quite a few studies have been 
done on knowledge, attitude and practices 
of prostate cancer and prostate cancer 
screening. These studies report a low level 
of awareness of prostate cancer and prostate 
cancer screening20, 21. A cross sectional study 
done in 2009 on a native African urban 
population showed that 78.8% had never 
heard of prostate cancer and 5.8% had heard 
of PSA. The study also showed that none of 
the respondents had taken the screening test21.
The target population under study is the 
male staff of the University of Lagos. The 
purpose of this study was to determine their 
knowledge relating to prostate cancer and 
prostate cancer screening, their attitude 
towards and uptake of prostate cancer 
screening, and factors influencing screening 
practices. The information obtained will help 
to determine how knowledgeable they are 
about the disease and its screening practice, 
since an adequate level of knowledge on the 
part of the subjects is a pre-condition for 
utilization of a screening program 22. 
MATERIALS AND METHODS                 
Background to study
The University of Lagos, south-west 
Nigeria, is a tertiary academic institution 
established in 1962. It provides instruction 
and facilities for the pursuit of high quality 
programmes through full-time, part-time 
and distance learning in diploma and post-
graduate categories.
The University is made up of two 
campuses: The main one at Akoka, Yaba 
and the College of Medicine of Lagos 
(CMUL) in Idi-Araba, Surulere. The main 
campus is situated within the Mainland 
Local Government Area in Akoka, bounded 
by Yaba, Onike, Bariga and the Lagos 
Lagoon.
From a modest intake of 131 students 
in 1962, enrollment has grown to over 
39.000. The University’s Akoka campus 
is composed of nine faculties, offering a 
total of 117 programmes in Arts, Social 
Sciences, Environmental Sciences, Pharmacy, 
Law, Engineering Sciences, Business 
Administration and Education. 
The CMUL is an autonomous unit of 
the University of Lagos since 1962. It 
has undergone various changes with the 
re-designation of its name from Medical 
School to College of Medicine, University 
of Lagos, by a decree of the Federal Military 
Government on 10th March 1967. This 
decree reconstituted the University of Lagos 
and incorporated the CMUL within it. The 
college is made up of three faculties: Basic 
Sciences, Clinical Sciences and Dental 
Sciences. 
The University of Lagos has a complex 
organizational structure requiring heterogeneous 
staff with their varied functions.
At the time of this study, the main 
campus had a total combined male and 
female staff of 3571, comprising of 943 
academic staff, 1537 non-academic senior 
staff and 1091 non-academic junior staff. 
The total male staff number was 2317, 
consisting of 700 academic staff, 916 
non- academic senior staff and 701 non-
academic junior staff.
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The CMUL had a total of 233 academic 
staff, 355 non-academic senior and 357 
non-academic junior staff. The total male 
staff number was 613, consisting of 143 
academic staff, 234 non-academic senior 
staff and 236 non-academic junior staff. 
The total male staff number of both 
campuses was 2930 (613+2317).
Study design: This is a descriptive cross-
sectional study of the knowledge, attitude 
and practice of prostate cancer screening 
among male staff of the University of Lagos.
Sampling methodology: Using appropriate 
formulae, the sample size was calculated to 
be 250. A multi-staged sampling technique 
was used to select respondents:  
Stage one 
Since these are heterogeneous groups, 
stratified sampling technique was used 
to select proportionate samples of the 
study population consisting of academic 
staff, non-academic senior staff and non-
academic junior staff of both campuses.
The total staff number of 2930 men was 
divided into:  
A. Academic staff of 843 (700 from 
main campus and 143 from CMUL)
B. Non-academic senior staff of 1150 
(916 from main campus and 234 from 
CMUL).
C. Non-academic junior staff of 937 
(701 from main campus and 236 from 
CMUL).
Proportions of the sample size of 
250 were calculated for each cadre and 
campus, yielding academic staff= 75 
(Akoka= 60, CMUL= 15), non-academic 
junior staff= 75, (Akoka= 60, CMUL= 15) 
non-academic senior staff= 100 (Akoka= 80, 
CMUL= 20). 
Stage two
Three different lists of all male staff 
were collected, one for each cadre of 
staff. The lists had the names of the staff, 
their units, departments and faculties 
where applicable. 
The academic male staff list was 
grouped into 9 Faculties (Arts, Business 
Administration, Education, Engineering, 
Environmental Science, Law, Pharmacy, 
Science and Social Sciences) for Akoka 
campus and three faculties of Basic Sciences, 
Clinical Sciences and Dental Sciences for 
CMUL campus.
The senior and junior non-academic 
staff lists consisted of staff in the same 
faculties as the academic staff list. 
Academic staff 
For the academic staff in Akoka campus, two 
faculties were randomly selected by simple 
ballot namely: Science and engineering. The 
engineering faculty has8 departments with 
101 male academic staff while the faculty 
of science has 9 departments with 120 male 
academic staff. These made a total of 221 
male academic staff in the two faculties from 
which 60 were randomly selected. 
For academic staff in the CMUL campus, 
there were three faculties comprising of 23 
departments. The faculty of clinical sciences 
was randomly selected by simple ballot. 
It consists of 11 departments. 
Akoka Campus
On the main campus, three departments were 
randomly selected from each of the selected 
faculties. From the faculty of science, the 
departments picked were chemistry (16 male 
staff), botany (17) and physics (28). From the 
faculty of engineering, the departments picked 
were civil engineering (19), mechanical 
engineering (20) and chemical engineering (22). 
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Ten respondents were randomly selected using 
simple ballot from each department until the 
desired number of 60 respondents was attained.
CMUL campus
In the CMUL campus, two of the 11 
departments from the faculty of clinical 
sciences were randomly selected by simple 
ballot. These were the departments of surgery 
(21 male staff) and medicine (9), from which 
10 and five respondents, respectively, were 
randomly selected.
Selection of junior and senior non-
academic staff
Similar approaches were used in the 
selection of both junior and senior non-
academic respondents from the same 
faculties and departments as those used 
for the academic staff in both campuses. 
In all, 56 and 19 junior non-academic 
respondents were randomly selected 
from the Akoka and CMUL campuses 
respectively. For the senior non-academic 
staff, 60 and 20 respondents were randomly 
selected from the Akoka and CMUL 
campuses respectively
Data collection tool and technique
A self- administered questionnaire adapted 
from previous studies25-27 was used to assess 
the respondents. It comprised both open and 
close ended questions. The draft questionnaire 
was pre-tested on male staff (20) at the Yaba 
College of technology, Yaba, Lagos and 
amended as appropriate. The questionnaire 
had four parts: Background information 
(socio-demographics), knowledge of prostate 
cancer and prostate screening, attitude 
towards prostate cancer screening, practice 
of prostate cancer screening.
Administration of the questionnaire was 
done every working day from 8 am to 4 
pm over a four week period (May–June 
2010). An average of five visits was made 
to each department to retrieve the completed 
questionnaire over another two weeks.
Data analysis
After collection, the questionnaires were 
appraised and answers to open ended 
questions were coded. Analysis was done 
using the EPI-INFO version 2007 software 
statistical package. Data were presented 
in the form of frequency tables and cross 
tabulations. Categorical variables in groups 
were compared using the Chi-square test. 
The level of significance was set at p <0.05.
Ethical considerations
Approval was obtained from the Department 
of Community Health and Primary Care 
of the University of Lagos. Participation 
in the study was voluntary, verbal consent 
was sought before questionnaires were 
administered. Subjects were assured of the 
confidentiality of the study.
Limitation of the study 
For some of the departments, all the staff in 
the selected cadre had to be used in the study.
RESULTS                                                    
The age group with the largest number of 
respondents was 41-49 years (32.0%) and with 
the lowest number was 60-69 years (16%). 
The mean age was 47.4±6 years. About 87.2% 
of the respondents were married, 42.4% 
had tertiary education, while 33.2% of them 
continued to postgraduate level and 65.6% 
were senior professionals. The majority of the 
respondents were Yoruba (76.8%) followed by 
Igbos (16%). Only 2 (0.8%) were Hausa and 
the remaining (6.4%) were from other tribes 
like Bini, Igala and Ibibio.
The largest cadre of respondents was the 
senior non-academic staff (40%) while both 
the junior non-academic and the academic 
respondents  constituted equal proportions of 30%.
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Knowledge of prostate cancer and 
screening
About two-thirds of respondents were 
aware of the prostate gland (65%) and 
prostate cancer (66%), 145 (58%) had 
heard of a screening test for prostate cancer, 
57.9% obtained their information from 
health workers, while 13.8% obtained their 
information from the media or a family 
member. Overall, 46.9% of those aware of 
screening methods knew of DRE, while 86 
(59.3%) knew of the PSA test (Table 2). 
Out of 164 respondents who knew about 
prostate cancer, 54.3% identified age as a 
risk factor while 39.6%, 31.1%, 30.5% and 
28% identified diet, race, family history 
of prostate cancer and cigarette smoking, 
respectively, as risk factors and 26.8 % 
could not identify any risk factor for prostate 
cancer. Of the respondents who claimed 
to be aware of prostate cancer, 23% could 
not mention any treatment method, 44.5% 
mentioned surgery, while 22.6%, 7.3% and 
2.4% identified drugs, radiation and watchful 
waiting, respectively, as treatment methods. 
Concerning complications of prostate cancer 
treatment, 48.8% of respondents who knew 
about prostate cancer mentioned impotence, 
35.4% mentioned incontinence and 46.3% 
had no knowledge of likely complications.
Attitude to prostate cancer and screening
Overall, 66.4% of respondents were 
concerned about getting prostate cancer 
while 13.6% were not and 20% did not know 
whether they were concerned or not. The 
majority (87.2%) of the respondents thought 
it was necessary to perform prostate screening 
in symptom-free individuals and 92.8% were 
willing to learn more about prostate cancer.
Practice of prostate cancer screening
Of the 71 (28.4%) respondents who had 
undergone at least one prostate cancer 
screening, 47.9% took the screening following 
their doctors’ suggestion as part of a 
routine health check, while 33.8% took it 
because they had heard it from the media. 
Of the 71.6% of respondents that had never 
undergone prostate cancer screening, 32.4% 
said they were not aware that such screening 
was available, 30.2% of them said their 
doctor never recommended it, 13.4% did not 
take the screening because they would not 
want to know the outcome, 11.2% of them 
thought it unnecessary and 12.3% thought the 
procedure might be painful (Table 3).
Disaggregating uptake of screening by 
campus, 77.3% of respondents that had 
undergone prostate screening were from 
the CMUL campus while only 27.7% were 
from the Akoka campus.
Associations
There was no statistically significant 
relationship between respondents’ age 
(p= 0.064), marital status (p= 0.236) and their 
awareness of the screening test. However, 
there was a statistically significant relationship 
between respondents’ age and practice of 
prostate cancer screening, (p= 0.000). With 
increasing age, uptake of screening increased, 
with 50% of respondents above 60 years 
having taken the test. Respondents’ level of 
education and cadre were also significantly 
associated with awareness and uptake of 
prostate cancer screening, p <0.000). As 
educational level increased, the awareness 
and uptake of prostate cancer screening 
increased. Academic respondents were more 
aware of (73.3%) and practiced more of 
the screening (41.3%) than the other cadre. 
However, there was no statistically significant 
relationship between their attitude towards 
screening and their cadre (Tables 4-5). 
While respondents’ age group and marital 
status were not significantly associated with 
their thought of the necessity for prostate 
screening, educational level significantly 
influenced their perception of the necessity 
for screening.
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Respondents’ awareness of prostate cancer 
and screening significantly influenced 
(p= 0.000) their uptake of prostate cancer 
screening (Table 5). Those who were aware 
of prostate cancer and available screening 
methods were more likely to be screened. 
While respondents’ cadre significantly 
influenced the rating of their health status, 
it did not influence either willingness to 
know more about prostate cancer and 
screening methods or their practice of these 
methods. Respondents who rated their health 
as excellent were the least likely to have 
undergone prostate cancer screening.
DISCUSSION                                               
The study was conducted among male staff 
of the University of Lagos and comprised 
250 men whose ages ranged between 30 and 
>60 years. More than half of them were in 
the 41-49 and 50-59 years age brackets (32% 
and 26.8%, respectively). The mean age was 
47.4±6 years. The majority of the respondents 
were married (87.2%). Overall, 42.4% had 
a tertiary education, 33.2% had a post-
graduate qualification and 65.6% were senior 
professionals. The majority of the respondents 
were Yoruba (76.8%). This could be attributed 
to the fact that the school is located in the 
south-west region of Nigeria. Three-quarters 
(75.2%) of the respondents perceived their 
health status as excellent or very good.
Overall, 64% of the respondents were aware 
of the prostate gland. This is lower than the 
percentages reported in studies performed in 
Australia10 and Jamaica 28 where awareness 
of the prostate gland was 95% and 71.8%, 
respectively. A positive association was 
found between the respondents ‘educational 
level, cadre and awareness of prostate gland. 
Respondents with a tertiary or post-graduate 
qualification (68.9% versus 90%) and in the 
academic cadre (86.7%) were most aware 
of the prostate gland. Similar findings were 
noted in the Jamaican study28 where a positive 
relationship existed between educational 
level and knowledge of the prostate gland. 
The majority of the respondents were 
aware of prostate cancer (65.6%). However 
there was no difference in their level of 
awareness. A lower percentage was recorded 
in a community survey of 280 randomly 
selected Irish men, aged 40-69 years, where 
a quarter had not heard of prostate cancer29. 
Fig. 1: Department categories of respondents (numbers expressed in absolute figures)
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In another study done in an urban population 
comprising mainly of civil servants (51.9%), 
78.8% had not heard of prostate cancer30. 
These differences may be due to the fact that 
this study was conducted in an academic 
environment, since cadre was positively 
associated with awareness of prostate cancer, 
with the academic respondents being the 
most aware (84%). 
Overall, 58% of the respondents were 
aware of a prostate cancer screening test. 
Awareness of screening was better among 




















Senior profession 164 (65.6)









Junior non-academic 75 (30.0)
Senior non-academic 100 (40.0)
Academic 75 (30.0)
Table 1: Socio-demographic characteristics of 
the respondents 
(73.8 % versus 26.2 %), probably because 
the respondents from a hospital environment 
were better informed about prostate 
cancer screening. In a telephone interview 
conducted in New Zealand, 52% knew that 
the cancer society recommended screening31. 
The commonest screening test known in the 
study was PSA (59.3%). This result differed 
from that done in an urban setting in 2009 
where only 5.8% of the participants had heard 
of PSA22. However the type of prostate cancer 
screening known by respondents from the 
two campuses differed. CMUL respondents 
were more aware of both methods. Of those 
that mentioned DRE and PSA, 67.6% and 
79.2%, respectively, were from the CMUL 
(p= 0.0000).
In this study, awareness of the screening 
tests increased with educational level, cadre 
and occupation, but not with age and marital 
status. Respondents with higher levels of 
education were more aware of prostate 
cancer screening. From this study, it is 
obvious that the junior cadre of respondents 
who were mainly the least educated, knew 
the least about prostate cancer screening 
(36.6%) and hence would require education 
on male reproductive health and preventive 
measures to achieve optimal health. This 
approach may positively influence their 
uptake of screening, since 81.3% thought it 
necessary for prostate cancer screening to 
be done in symptom-free individuals. 
In this study, the attitude of the respondents 
to prostate screening was positive as 66.4% 
were concerned about getting prostate 
cancer and 87.2% were of the opinion that 
screening should be done in symptom-free 
individuals. A positive association was noted 
between respondents’ attitude to prostate 
cancer screening and their educational 
level. The respondents with tertiary and 
post-graduate education felt the most need 
for routine screening in symptom-free 
individuals (90.6% and 88%, respectively). 
In a cross-sectional telephone survey in New 
Zealand, 94% believed having routine health 
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examination was important and 81% felt it 
was necessary to test for prostate cancer in 
symptom-free individuals31.
Prostate cancer risk factors most 
recognized were age (54.3%), diet (39.6%), 
race (31.1%), family history of prostate 
cancer (30.5%) and cigarette smoking 
(28.8%). Dribbling was the commonest 
symptom selected by the respondents 
(46.3%). This was followed by a weak 
urinary stream (30.5%). The least common 
symptom identified by the respondents 
was stopping and starting urination 
(intermittency) (22%). A study done in New 
Zealand on 120 respondents (42-79 years) 
showed that 32% of them picked either 
dribbling or weak urinary stream and only 
one selected intermittency31. Treatment 
modalities identified for prostate cancer 
by the respondents were mainly surgery 
(44.5%) and drugs (22.6%), whereas 
only 7.3% identified radiation. This is 
slightly different from a study done on 503 
respondents in Western Australia where 54% 
identified surgery, 26% identified radiation 
therapy and 24% identified drugs/hormonal 
treatment. The side-effects of treatment 
identified by the respondents in this study 
included impotence (50%) and incontinence 
(35.5%) whereas 46.3% had no idea of the 
side-effects of prostate cancer treatment. In 
the Western Australian study, 53% had no 
idea about the side-effects of treatment10. 
Uptake of screening tests in the study was 
low in both campuses (27.8% versus 26% in 
CMUL versus Akoka). This finding differs 
from studies done in New Zealand Western 
Australia and New Mexico, where 55%, 
Ever heard of prostate gland n (%)
Yes 162 (64.8)
No 88 (35.2)
Ever heard of prostate cancer
Yes 164 (65.6)
No 86 (34.4)
Ever heard of prostate cancer screening 
Yes 145 (58.0)
No 105 (42.0)
Major sources of information on prostate cancer screening 
Family 20 (13.8)
Friends 15 (10.3)
Health workers 84 (57.9)
Media 20 (13.8)
Internet, books 9 (6.2)
School 2 (1.4)
Type of screening test known 
Digital rectal examination (DRE) 68 (46.9) 
Prostate specific antigen (PSA) 86 (59.3) 
Table 2: Awareness of prostate cancer and screening
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Ever undergone a screening test 
Yes 71 (28.4)
No 179 (71.6)
Type of screening test undergone
Digital Rectal Examination (DRE) 24 (33.8)
Prostate Specific Antigen (PSA) 39 (54.9)
Can not remember 8 (11.3)
Reasons for screening for prostate cancer
Had symptoms of prostate cancer 24 (33.8)
Wife or friend recommended it 4 (5.6)
Media publicity 4 (5.6)
Doctor suggested it as part of a regular health check 34 (47.9)
Reasons for not screening for prostate cancer
I do not know such test 58 (32.4)
It might be painful 22 (12.3)
It might be expensive 6 (3.4)
Do not want to know the outcome 24 (13.4)
It is not necessary 20 (11.2)
Doctor has never recommended it 54 (30.2)
Table 3: Practice of prostate screening
56% and 48%, respectively, of participants 
had been tested for prostate cancer10, 26,31.  
The commonest reasons for not undergoing 
prostate cancer screening were not being 
aware of such a test (32.4%) and that their 
doctors never recommended it (30.2%). 
Of the 277 participants in a study in the USA, 
53.4% of the respondents indicated that the 
doctor had never told them they needed a 
PSA. The respondents opined that they did 
not have prostate cancer screening because 
they were not aware they should be screened 
(79.5%), they believed they were not at risk 
(78.4%) or the doctor never mentioned it 
(66.7%)32. These findings show that both 
the media and health professionals have 
a role to play in creating awareness about 
prostate cancer screening. Also not providing 
information about prostate screening by 
physicians may lead to ignorance and hence 
reduced screening uptake. In a study carried 
out in Jamaica on 169 rural health workers, 
31.6% stated that cost was the major reason 
for not participating in prostate cancer 
screening33. It contrasts with this study where 
cost was not a major factor (3.3%).
A statistically significant relationship was 
found between the respondents’ awareness 
of prostate cancer, awareness of screening 
tests and the prostate screening practice, 
respectively. Age, educational level, cadre, 
and occupation were positively associated 
with uptake of screening. In this study, 
uptake of prostate screening increased with 
age, since 50% of respondents >60 years 
had been screened. Findings from a similar 
study done in Nebraska showed that men 
were more likely to accept PSA testing if 
they were older than 50 years of age34.
In this study, it was also noted that the 
academic respondents who were aware 
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Age (years) Awareness of screening test P-value
30-40 33 (51.6)
41-49 53(66.3)




Married 125 (57.3) 0.236
Separated 2 (33.3)
Education





Junior non-academic 27 (36.0)
Senior non-academic 63 (63.0) 0.000*
Academic 55 (73.3)
Table 4: Association between socio-demographic characteristics of respondents and awareness of 
prostate screening test
of prostate cancer screening still had a 
higher (41.3%) uptake when compared 
with the other cadres (senior= 24% and 
junior= 14.7%). The senior professionals 
were the most screened for prostate cancer 
(32.4%). All of the unskilled respondents 
had not undergone prostate screening. 
This difference in screening uptake may 
be due to the fact that professionals were 
more educated and likely earned higher 
incomes and hence could afford the cost 
of screening. Some studies have reported 
that men of higher socio-economic status 
reported more frequent prostate cancer 
screening than men of lower socio-economic 
status 35-37.
Studies have identified lack of awareness, 
fear, cultural and religious beliefs, 
traditional attitudes about male gender 
role, physician’s attitude as well as sexual 
dysfunction as sensitive issues for black 
men which discouraged their involvement 
in prostate cancer screening38-40. 
In conclusion, the study revealed that 
although the male staff members of the 
University of Lagos were aware of prostate 
cancer, about half of them were aware of 
prostate screening and mostly obtained 
information from health workers. Although 
the majority indicated the necessity for 
screening in symptom-free individuals, very 
few of them had undergone prostate screening 
following their doctors’ recommendation 
as part of a routine health check. Factors 
associated with uptake of prostate cancer 
screening among the respondents were their 
occupation, educational level, awareness 
and their dependence on their doctors to 
recommended screening.
In view of a lack of consensus on the need 
for screening for prostate cancer in all men, 
arising from insufficient scientific evidence 
to decide if prostate cancer screening is 
beneficial for men younger than 75 years old, 
the authors recommend informed decision 
making, in which men are to talk with 
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their doctors to learn the nature and risks 
of prostate cancer, understand the benefits and 
risks of the screening tests and decide whether 
prostate cancer screening is right for them.
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